Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Does Prophylactic Phototherapy Prevent Hyperbilirubinemia in Neonates with ABO Incompatibility and Positive Coombs' Test?

Journal of Perinatology volume 25, pages 590–594 (2005)Cite this article

Abstract

OBJECTIVE:

The objective of the study was to determine whether initiation of early phototherapy in positive direct Coombs' test (DCT) with ABO-incompatible newborns would prevent severe jaundice.

STUDY DESIGN:

A prospective controlled study was performed at Al Qassimi Hospital. Infants born at term and weighing >2000 g with ABO incompatibility and a positive DCT were included in the study. Within their first 4 hours of life and after parental consent, infants were enrolled into one of two groups: prophylactic phototherapy group, which received phototherapy during the first 24 hours of life (group I), or no prophylactic phototherapy, which represents the control group (group II). Selection of infants to either group was by 2-week alternative strategy.

Blood group, complete blood count (CBC), reticulocyte count, blood smears, total serum bilirubin (TSB) and DCT were performed on cord blood of all neonates born to mothers with O-positive blood group. CBC, reticulocytes and TSB level were obtained in all enrolled infants at 12, 24, 48, 72, and 96 hours of life.

RESULTS:

During the study period, 242 newborns with positive DCT were enrolled. A total of 102 infants were allocated to the prophylactic phototherapy arm and 140 as controls.

Prophylactic phototherapy was associated with a significant decrease in the TSB at 24 hours (p=0.002) and at 48 hours (p=0.003) but not later on. The total number of patients who had hyperbilirubinemia at any time during the first 96 hours was significantly less in the prophylactic group (17 vs 45 — p=0.006). Prolonged hospital stay because of phototherapy was more frequent in the control group (p=0.03).

CONCLUSION:

Prophylactic phototherapy was associated with a significant reduction of TSB in the first 48 hours of life but not later on. Clinical benefits of this strategy could not be proven.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Maisels J, Kring E . Length of stay, jaundice and hospital readmission. Pediatrics 1998;101:995–998.

    Article  CAS  PubMed  Google Scholar 

  2. Mitchell S, Mathura N . Identifying infants who might benefit from routine measurement of bilirubin during first 48–72 hours of life. BMJ 2000;320:119.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Stoll B, Kliegman R . Blood disorders. In: Behrman R, Kliegman R, Jenson H, editors. Nelson Textbook of Pediatrics. 17th ed. Pennsylvania: Saunders Co.; 2004. p. 599–608.

    Google Scholar 

  4. Sarici SU, Yurdakok M, Serdan MA . An early 6-hour serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease. Pediatrics 2002;109:e53.

    Article  PubMed  Google Scholar 

  5. Orzalesi M, Gloria F, Lucarelli P, Bottini E . ABO system incompatibility: relationship between direct Coombs' test positivity and neonatal jaundice. Pediatrics 1973;51:288–289.

    CAS  PubMed  Google Scholar 

  6. Maisels MJ, Newman TB . Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995;96:730–733.

    CAS  PubMed  Google Scholar 

  7. Osborn LM, Lenarsky C, Oakes R, Reiff M . Phototherapy in full term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics 1984;74:371–374.

    CAS  PubMed  Google Scholar 

  8. Bhutani VK, Johnson L, Sivieri EM . Predictive ability of pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy and near-term newborns. Pediatrics 1999;103:6–14.

    Article  CAS  PubMed  Google Scholar 

  9. Stanley IP, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Peditatrics 2004;114:e130–e153.

    Article  Google Scholar 

  10. Brown AK, Kim MH, Wu YK, Bryla DA . Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985;75:393–400.

    CAS  PubMed  Google Scholar 

  11. Maurer HM, Kirkpatrick BV, Me Williams NB . Phototherapy for hyperbilirubinemia of hemolytic disease of the newborn. Pediatrics 1985;75:407–412.

    CAS  PubMed  Google Scholar 

  12. Subcommittee on hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.

  13. Risemberg HM, Mazzi E, Macdonald MG, Heldrich F . Correlation of cord bilirubin levels with hyperbilirubinemia in ABO incompatibility. Arch Dis Child 1977;52:219–222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Chen JY, Chung H . Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. Chin Med J 1994;53:13–18.

    CAS  Google Scholar 

  15. Levine D, Meyer B . Newborn screening for ABO haemolytic disease. Clin Paediatr 1985;24:391–394.

    Article  CAS  Google Scholar 

  16. Alpay F, Sarici SU, Tosuncuk HD, Serdar MA . The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics 2000;106:e16.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We extend our thanks and gratitude to Pr. Khalid Haque Reader in Neonatal Pediatrics, University of London and Consultant Neonatologist at Queen Mary children hospital in UK, and to Professors Arne Ohlsson and Balf from the University of Toronto for their helpful comments. We also thank Ms. Noha Yaseen for typing this manuscript.

Author information

Authors and Affiliations

  1. Pediatric/Neonatal Department (H.Y., M.K.), Al Qassimi Hospital, Sharjah, United Arab Emirates

    Hakam Yaseen MD, CES, DUN (France), FRCPCH (UK) & Mona Khalaf MRCP

  2. Laboratory Department (N.R.), Al Qassimi Hospital, United Arab Emirates

    Najat Rashid PhD

  3. Pediatrics Department (M.D.), Al Falah Hospital, Sharjah, United Arab Emirates

    Maha Darwich MD, CES

Authors
  1. Hakam Yaseen MD, CES, DUN (France), FRCPCH (UK)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mona Khalaf MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Najat Rashid PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maha Darwich MD, CES
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yaseen, H., Khalaf, M., Rashid, N. et al. Does Prophylactic Phototherapy Prevent Hyperbilirubinemia in Neonates with ABO Incompatibility and Positive Coombs' Test?. J Perinatol 25, 590–594 (2005). https://doi.org/10.1038/sj.jp.7211356

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211356

This article is cited by

Search

Advanced search

Quick links